FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

16592911000001100: Canakinumab 150mg powder for solution for injection vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57965901000001114 Canakinumab 150mg powder for solution for injection vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57966001000001117 Canakinumab 150mg powder for solution for injection vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Canakinumab 150mg powder for solution for injection vials Is a Canakinumab true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has active ingredient Canakinumab false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Subcutaneous route true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninjection.subcutaneous ontology form and route true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Is a Canakinumab false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has dispensed dose form Powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has specific active ingredient Canakinumab false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has active ingredient Monoclonal antibody false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has specific active ingredient Canakinumab true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Is a Product containing canakinumab false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ilaris 150mg powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd) Is a True Canakinumab 150mg powder for solution for injection vials Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial Has VMP True Canakinumab 150mg powder for solution for injection vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start